177 related articles for article (PubMed ID: 7584794)
1. Fibrinogen and cardiovascular risk.
Heinrich J; Assmann G
J Cardiovasc Risk; 1995 Jun; 2(3):197-205. PubMed ID: 7584794
[TBL] [Abstract][Full Text] [Related]
2. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
3. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
Jaeger BR; Labarrere CA
Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
[TBL] [Abstract][Full Text] [Related]
4. Inter-relationships of plasma fibrinogen, low-density lipoprotein cholesterol, cigarette smoking and the prevalence of cardiovascular disease.
Fowkes FG; Lee AJ; Lowe GD; Riemersma RA; Housley E
J Cardiovasc Risk; 1996 Jun; 3(3):307-11. PubMed ID: 8863104
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen and cardiovascular disorders.
Lip GY
QJM; 1995 Mar; 88(3):155-65. PubMed ID: 7767665
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
Ernst E
Eur Heart J; 1993 Dec; 14 Suppl K():82-7. PubMed ID: 8131795
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen as a risk factor for coronary heart disease.
Montalescot G; Collet JP; Choussat R; Thomas D
Eur Heart J; 1998 Jul; 19 Suppl H():H11-7. PubMed ID: 9717059
[TBL] [Abstract][Full Text] [Related]
8. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study.
Lowe G; Rumley A; Norrie J; Ford I; Shepherd J; Cobbe S; Macfarlane P; Packard C
Thromb Haemost; 2000 Oct; 84(4):553-8. PubMed ID: 11057849
[TBL] [Abstract][Full Text] [Related]
9. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
[TBL] [Abstract][Full Text] [Related]
10. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
Assmann G; Cullen P; Heinrich J; Schulte H
Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642
[TBL] [Abstract][Full Text] [Related]
11. [Fibrinogen, a vascular risk factor].
Caen JP; Soria J; Collet JP; Soria C
Bull Acad Natl Med; 1993 Nov; 177(8):1433-41; discussion 1441-4. PubMed ID: 8193948
[TBL] [Abstract][Full Text] [Related]
12. Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study.
Engström G; Hedblad B; Stavenow L; Jonsson S; Lind P; Janzon L; Lindgärde F
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1498-502. PubMed ID: 15178569
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
14. Plasma viscosity and related cardiovascular risk factors in a Spanish Mediterranean population.
Vayá A; Simó M; Santaolaria M; Carrasco P; Corella D
Thromb Res; 2007; 120(4):489-95. PubMed ID: 17215030
[TBL] [Abstract][Full Text] [Related]
15. [Plasma fibrinogen and cardiovascular disease].
Møller LF; Jespersen J; Kristensen TS
Ugeskr Laeger; 1991 Aug; 153(34):2343-5. PubMed ID: 1897044
[TBL] [Abstract][Full Text] [Related]
16. [Fibrinogen as a cardiovascular risk factor--marker or causal factor?].
Halvorsen S
Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2829-32. PubMed ID: 10494205
[TBL] [Abstract][Full Text] [Related]
17. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
Engström G; Hedblad B; Janzon L; Lindgärde F
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
[TBL] [Abstract][Full Text] [Related]
18. [Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
Wöhrle J; Nusser T; Hoffmeister A; Kestler HA; Grebe OC; Höher M; Hombach V; Koenig W; Kochs M
Dtsch Med Wochenschr; 2003 Jun; 128(24):1333-7. PubMed ID: 12802741
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen: its role in the hemostatic regulation in atherosclerosis.
Eber B; Schumacher M
Semin Thromb Hemost; 1993; 19(2):104-7. PubMed ID: 8356454
[TBL] [Abstract][Full Text] [Related]
20. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
